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Recent studies have suggested that a signiﬁcant fraction of the human genome is contained in blocks of strong
linkage disequilibrium, ranging from ∼5 to 1100 kb in length, and that within these blocks a few common haplotypes
may account for 190% of the observed haplotypes. Furthermore, previous studies have suggested that common
haplotypes in candidate genes are generally shared across populations and represent the majority of chromosomes
in each population. The conclusions drawn from these preliminary studies, however, are based on an incomplete
knowledge of the variation in the regions examined. To bridge this gap in knowledge, we have completely rese-
quenced 100 candidate genes in a population of African descent and one of European descent. Although these
genes have been well studied because of their medical importance, we demonstrate that a large amount of sequence
variation has not yet been described. We also report that the average number of inferred haplotypes per gene, when
complete data is used, is higher than in previous reports and that the number and proportion of all haplotypes
represented by common haplotypes per gene is variable. Furthermore, we demonstrate that haplotypes shared
between the two populations constitute only a fraction of the total number of haplotypes observed and that these
shared haplotypes represent fewer of the African-descent chromosomes than was expected from previous studies.
Finally, we show that restricting variation discovery to coding regions does not adequately describe all common
haplotypes or the true haplotype block structure observed when all common variation is used to infer haplotypes.
These data, derived from complete knowledge of genetic variation in these genes, suggest that the haplotype
architecture of candidate genes across the human genome is more complex than previously suggested, with important
implications for candidate gene and genomewide association studies.
Introduction
Candidate gene association studies have been suggested
as a powerful study design for the identiﬁcation of com-
mon genetic variants involved in common diseases
(Risch and Merikangas 1996; Collins et al. 1997). In
the simplest of study designs, the frequency of the causal
variant(s) is expected to be greater among cases than
among controls. For numerous reasons, including in-
sufﬁcient sample size and genetic heterogeneity among
cases, studies employing this design have had little suc-
cess (Ioannidis et al. 2001; Lohmueller et al. 2003). An-
other possible explanation for the mixed success of these
studies is that they typically examine the relationship
between a particular phenotype and a single marker
within a candidate gene. If the marker surveyed is not
Received September 25, 2003; accepted for publication December
17, 2003; electronically published March 10, 2004.
Address for correspondence and reprints: Dr. Dana C. Crawford or
Dr. Deborah A. Nickerson, Department of Genome Sciences, Univer-
sity of Washington, Box 357730, Seattle, WA 98195-7730. E-mail:
dcrawfo@gs.washington.edu or debnick@u.washington.edu
 2004 by The American Society of Human Genetics. All rights reserved.
0002-9297/2004/7404-0003$15.00
the causal variant, this approach relies on the assump-
tion that there is linkage disequilibrium or allelic asso-
ciation between the causal variant and the marker sur-
veyed. Without prior knowledge of the complete genetic
variation within the candidate gene or of the structure
of linkage disequilibrium in the region, both positive and
negative results must be interpreted with caution (re-
viewed by Cardon and Bell [2001]).
With the recent development of affordable high-
throughput sequencing technology, it is now possible to
fully catalogue genetic variation in candidate regions
for various populations. The most common form of
human variation is the SNP: 11 million SNPs with mi-
nor allele frequencies of at least 1% are estimated to
exist in the human genome, with an average spacing of
1 SNP every 290 bp (Kruglyak and Nickerson 2001).
SNPs occurring within regions of functional signiﬁ-
cance—such as coding regions, splice junctions, and
promoter regions—are of particular interest, because
changes in these genic regions have been shown to be
the most common causes of Mendelian disease and are
hypothesized to contribute to common, complex dis-
eases as well (reviewed by Botstein and Risch [2003]).
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Given the potential applications to genotype-phenotype
and disease-gene localization studies, a major goal of
the past and current 5-year plans of the HumanGenome
Project is to catalogue common human variation (Col-
lins et al. 1998, 2003). Both private (Venter et al. 2001)
and public (Sachidanandam et al. 2001) resources have
been created to facilitate the collection and mining of
genetic variation in candidate genes (Coronini et al.
2003), and recent examinations of the public collection
suggested that it is adequate for association studies in
at least one population (Carlson et al. 2003; Reich et
al. 2003).
In addition to the continuing efforts in human vari-
ation discovery, the next challenge is harnessing the in-
formation garnered from these efforts to understand the
relationship between genotypes and phenotypes (Collins
et al. 2003). Because it is currently infeasible to genotype
every available SNP in a genetic-association study, key
questions include which and how many SNPs must be
chosen for an association study so that it has sufﬁcient
power to detect an association with a disease-causing
variant (Kruglyak 1999). To answer these questions, it
is important to describe the amount of linkage dis-
equilibrium and the properties of haplotype structure
across the human genome. Several studies have recently
suggested that the human genome can be organized into
haplotype blocks such that blocks are deﬁned as regions
of strong linkage disequilibrium (Daly et al. 2001; Patil
et al. 2001; Dawson et al. 2002; Gabriel et al. 2002;
Phillips et al. 2003). Generally, the few haplotypes
within these blocks can be resolved with a few SNPs,
greatly reducing the number of SNPs required for an
association study. Haplotype blocks are separated by
regions exhibiting low levels of linkage disequilibrium,
consistent with evidence of historical recombination.
Local hotspots of recombination (Daly et al. 2001; Jef-
freys et al. 2001; Gabriel et al. 2002), as well as sto-
chastic recombination events and other forces (Subrah-
manyan et al. 2001; Wang et al. 2002; Phillips et al.
2003; Zhang et al. 2003), have been proposed as factors
that shape block lengths across the genome. Inspired by
these results, the International HapMap Project has
been launched to produce a genomewide haplotypemap
in several world populations for association studies (re-
viewed by Wall and Pritchard [2003]).
Given the heightened interest in haplotype structure
across the human genome, we sought to describe hap-
lotype diversity within a European-descent (ED) and an
African-descent (AD) population across 100 candidate
genes related to inﬂammation, lipid metabolism, and
and blood pressure regulation. The candidate genes cho-
sen for analysis were completely resequenced for dis-
covery of variation in 47 individuals; thus, these data
represent one of the most comprehensive catalogues of
genetic variation for these genes, many of which have
been targets of previous SNP discovery efforts (Cambien
et al. 1999; Halushka et al. 1999; Stephens et al. 2001a;
Nakajima et al. 2002; Taylor et al. 2002; Tiret et al.
2002). Given this comprehensive collection of genetic
variation, we show that the average number of SNPs
per gene is higher for these candidate genes in both
populations than previously documented, as is the num-
ber of common SNPs. Furthermore, using the variation
identiﬁed through our resequencing efforts, we dem-
onstrate that the number of inferred haplotypes per gene
varies greatly across genes as well as between the two
populations within genes. Also, the proportion of chro-
mosomes represented by haplotypes shared between the
two populations is lower than previous estimates. Fi-
nally, we show that reducing the number of SNPs from
all common SNPs to a subset representing common cod-
ing variation reduces the number of common haplotypes
and increases the apparent size of haplotype blocks ob-
served. These data have important implications for the
use of haplotypes in candidate gene association studies
and genomewide studies in populations with different
histories.
Material and Methods
Variation Discovery
As part of an ongoing project known as the
“SeattleSNPs Program for Genomic Applications”
(PGA), we resequenced 1100 genes involved in the in-
ﬂammation process for the purpose of cataloguing com-
mon DNA variation. A list of completed genes, as well
as a list of genes in progress and under consideration
for resequencing, can be found on the University of
Washington–Fred Hutchinson Cancer Research Center
(UW-FHCRC) Variation Discovery Resource Web site.
For each gene, we resequenced the genomic region span-
ning the longest reference transcript in LocusLink, in-
cluding exons and introns, ∼2,500 base pairs (bp) up-
stream of the gene and ∼1,500 bp downstream of the
gene. All DNA variation data identiﬁed through these
resequencing efforts and the corresponding individual
genotypes and allele frequencies were deposited into
GenBank and dbSNP and are available on our Web site.
A small proportion of the genes described here (ACE,
AGT, AGTR1, APOB, HMGCR, LDLR, and REN)
were resequenced for other projects related to the in-
vestigation of lipid metabolism and the renin-angioten-
sinogen system (Rieder et al. 1999) as part of a Phar-
macogenetics Research Network. The chromosomal
locations of the 100 genes presented here are available
in table A1 (online only).
Each gene was resequenced for variation discovery in
two populations: an ED population ( ) and annp 23
AD population (of African Americans; ). The ex-np 24
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pected detection rate for common (15% minor allele
frequency) SNPs with these sample sizes has been esti-
mated at 99%, whereas the detection rate for all SNPs
(11%minor allele frequency) has been estimated at 87%
(Kruglyak and Nickerson 2001). On the basis of these
sample sizes, the allele and haplotype frequencies from
this survey are expected to be similar to frequencies es-
timated in larger populations. We genotyped 43 sites
across 6 genes in 408 control individuals and found that
allele frequencies from this larger sample are strongly
correlated with allele frequencies estimated from this re-
sequencing survey ( ; data not shown).2R p 0.83
All DNAs representing healthy individuals were ob-
tained from Coriell Cell Repository. Samples representing
the AD population were selected from the African-Amer-
ican Human Variation Panel (HD50AA: individuals
NA17101-17116 andNA17133-NA17140), and samples
representing the ED population were selected from avail-
able Centre d’Etude du Polymorphisme Humain (CEPH)
reference panel DNAs. The Coriell Cell Repository num-
bers for each of the CEPH samples resequenced for SNP
discovery described here are NA06990, NA07019,
NA07348, NA07349, NA10830, NA10831, NA10842,
NA10843, NA10842-NA10845, NA10848, NA10850-
NA10854, NA10857, NA10858, NA10860, NA10861,
NA12547, NA12548, and NA12560.
A complete description of our resequencing protocol
can be found on the UW-FHCRC Variation Discovery
ResourceWeb site. In brief, overlapping primers for PCR
were designed to span the gene, with an average am-
plicon size of 980 bp and an average overlap between
amplicons of 197 bp. The PCR products were sequenced
using standard dye primer and termination chemistry on
an ABI 3700. Data analysts assembled the sequence data
for each gene onto a reference genomic sequence, using
Phred and Phrap, and edited the resulting alignments for
accuracy, using Consed. Polymorphisms were then iden-
tiﬁed, using PolyPhred 4.0, from pairwise comparisons
of individual sequence chromatograms within regions
with an average quality score 140 using Phred. Analysts
reviewed all polymorphisms identiﬁed by PolyPhred for
false positives associated with features of the surround-
ing sequence or biochemical artifacts. If the polymor-
phism identiﬁed was an insertion/deletion polymor-
phism, analysts manually genotyped each sample and
designed primers from the other strand to sequence past
the polymorphism. Using this protocol for variation dis-
covery, we recently determined that the error rate is well
below 1% for genotype calls from the sequence data
(Carlson et al. 2003).
Statistical Methods
For all analyses described here, 100 genes in which
185% of the gene was successfully resequenced for SNP
discovery were considered (see table A1 [online only] for
a list of individual genes). Haplotypes were inferred by
the statistical software package PHASE, version 1.0.1
(Stephens et al. 2001b), which allows for missing ge-
notype data and a large number of sites per gene. Hap-
lotypes were inferred using the default settings of PHASE
from genotype data using either all biallelic polymor-
phisms available or biallelic polymorphisms with a mi-
nor allele frequency 15% present in each population
(African-descent and European-descent), as well as for
combined genotype data from both populations (here-
after referred to as the “combined” sample). To mimic
a variation discovery strategy targeting coding regions,
we simulated the resequencing strategy reported by Ste-
phens et al. (2001a) by selecting common SNPs (MAF
15%) from exons, 100 bp of introns on each side of
each exon, 1 kb upstream of the gene, and 100 bp down-
stream of the gene. Haplotypes were then inferred using
PHASE.
We calculated descriptive summary statistics for each
gene (total number of haplotypes, mean number of hap-
lotypes, median number of haplotypes, standard devi-
ation, and variance). A linear regression was performed
on the number of haplotypes per gene in the ED pop-
ulation versus the number of haplotypes per gene in the
AD population to describe differences in haplotype di-
versity within a gene between populations. We also cal-
culated descriptive summary statistics on the effective
number of haplotypes for all 100 genes. The effective
number of haplotypes, analogous to the effective number
of alleles (Ewens 1964; Hartl and Clark 1997), was cal-
culated as , where is the frequency of the2n p 1/Sp pe i i
ith haplotype and ne is the effective number of haplo-
types. Expected haplotype heterozygosity (H) was cal-
culated using the equation , where ne is the1 (1/n )e
effective number of haplotypes. The maximum possible
number of haplotypes in the absence of intragenic re-
combination, gene conversion, and recurrent mutation
was calculated as , where s is the numbermin (s 1,2x)
of biallelic polymorphisms per gene and x is the sample
size.
To compare sharing of similar (but not identical) hap-
lotypes between populations, divergence between hap-
lotypes was measured as the number of alleles that dif-
fered between a pair of haplotypes given the size of the
gene. For example, for a 15-kb gene, 0.02% haplotype
divergence would describe a pair of haplotypes which
differed at three sites.
The focus of most analyses presented here is to de-
scribe the distribution of haplotypes in terms of number
of haplotypes and frequency of haplotypes for each can-
didate gene. Previous studies of PHASE have demon-
strated that eliminating rare sites from the data set im-
proves the accuracy of haplotype inference (Lin et al.
2002) and that the software estimates haplotype fre-
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Table 1
Total Number of SNPs in 100 Candidate Genes Related to Inﬂammation, Lipid
Metabolism, and Blood Pressure Regulation, by Population
Population (No.
of Chromosomes)
No. of
SNPs
No. of SNPs
per kb
No. of SNPs
with MAF 15%
No. of SNPs
with MAF 15%,
per kb
AD (48) 7,793 4.71 4,360 2.64
ED (46) 4,620 2.79 3,053 1.85
Combined (94) 8,877 5.37 3,992 2.41
quencies well (Xu 2002), compared with molecularly
determined haplotypes. To test the accuracy of the num-
ber of haplotypes per gene inferred by PHASE, we in-
ferred haplotypes in a data set of four X-linked genes
containing 24 males. We duplicated the haplotypes and
then randomly paired the X-chromosomes to create a
diploid, “mixed male” data set. These four genes (ACE2,
AGTR2, PFC, and F9) had a total of 124 sites at MAF
15% for an average of 24.8 sites per gene. We then
compared the number of haplotypes inferred from this
mixed male data set at MAF 15% with known haplo-
types from the 24 males. The number of haplotypes per
gene observed in the inferred mixed male data set cor-
related well with the “true” number of haplotypes ob-
served ( ). Thus, the relative distribution of2R p 0.97
haplotypes described here is expected to be accurate.
Sites that “tag” or resolve common haplotypes (15%
frequency) and haplotypes inferred from coding varia-
tion (MAF 15%) were identiﬁed for each gene either
manually or by implementing SNPtagger (Ke and Car-
don 2003) at default settings. Haplotype blocks were
deﬁned using the four-gamete test implemented in the
program HaploBlockFinder (Zhang and Jin 2003) at de-
fault settings. The four-gamete test performs a pairwise
comparison of all SNPs to determine if all four possible
haplotypes are present in the population surveyed. If all
four haplotypes are present in the population surveyed,
, indicating evidence of historical recombination.′D ! 1
Block boundaries, therefore, are determined by SNPs
whose pairwise comparisons show evidence of historical
recombination (Wang et al. 2002). To apply a less strin-
gent deﬁnition of blocks, we set the minimal D′ range
to 0.80 in HaploBlockFinder at default settings.
Results
Variation Discovery
One hundred genes, with an average size of 16.5 kb
and spanning 18 autosomes, were completely resequ-
enced in two populations with different demographic
histories: AD and ED. Both populations were ascer-
tained through the Coriell Cell Repository (the African-
American Human Variation Panel HD50AA and unre-
lated individuals drawn from the parental generation of
the CEPH pedigrees). Resequencing 1,616 kb of refer-
ence sequence across the human genome identiﬁed a to-
tal of 8,877 biallelic polymorphisms in the combined
sample, with 7,793 and 4,620 in the AD and ED pop-
ulations, respectively (table 1). These sites should rep-
resent nearly complete ascertainment of variable sites in
the discovery samples and are expected to describe
∼99% of frequent variants in the broader population
(Kruglyak and Nickerson 2001).
For every gene, the number of biallelic polymorphic
sites was greater in the AD population than in the ED
population. Overall, the majority of the biallelic poly-
morphisms identiﬁed were SNPs ( ), with thenp 8,397
remainder representing insertion/deletions ( ).np 480
All analyses included both SNPs and biallelic indels
(hereafter collectively referred to as SNPs). On average,
the density of SNPs identiﬁed in the combined sample
and the AD and ED populations, across all 100 genes,
was 5.4, 4.7, and 2.8 SNPs per kb, respectively (table
1), which is comparable to reports from other large sur-
veys (Halushka et al. 1999; Stephens et al. 2001a;
Schneider et al. 2003). However, the mean number of
SNPs per gene (89, 78, and 46 in the combined sample
and the AD and ED populations, respectively) was
higher compared with previous reports. Also, we iden-
tiﬁed a greater number of SNPs in genes that were pre-
viously included in other large surveys. As an example,
we identiﬁed a total of 195 SNPs in ApoB compared
with 24 sites identiﬁed for the same gene in a separate
discovery effort (Cambien et al. 1999). This difference
reﬂects the fact that the present survey resequenced the
entire gene in two distinct populations rather than per-
forming SNP discovery on selected portions of each gene
(Cambien et al. 1999; Cargill et al. 1999; Stephens et
al. 2001a; Tiret et al. 2002) or in a single population
(Haga et al. 2002).
On the Number of Haplotypes
Haplotypes were statistically inferred from genotypes
by use of the software PHASE (Stephens et al. 2001b),
a method that has been shown to accurately infer hap-
lotypes (Lin et al. 2002) and to accurately estimate over-
all haplotype frequencies from diploid sequence data
(Xu et al. 2002). Totals of 4,278, 2,826, and 1,844 hap-
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Figure 1 The average number of haplotypes (blackened bars)
and effective haplotypes (gray bars) per gene inferred from common
SNPs (MAF 15%), by population. X-axis: population; Y-axis: the av-
erage number per gene. The thin bars represent the standard deviation.
Table 2
Total Number of Inferred Haplotypes and Average Expected Haplotype
Heterozygosity in 100 Candidate Genes Related to Inﬂammation, Lipid
Metabolism, and Blood Pressure Regulation, by Population
Population (No.
of Chromosomes)
No. of
Haplotypes
(All SNPs) H
No. of
Haplotypes
for SNPs
with MAF 15%
H for SNPs
with MAF 15%
AD (48) 2,826 .92 2,263 .90
ED (46) 1,844 .83 1,323 .78
Combined (94) 4,278 .91 3,007 .87
lotypes, corresponding to an average of 43, 28, and 18
haplotypes per gene, were identiﬁed in the combined
sample and the AD and ED populations, respectively
(table 2). None of the genes in either the AD or ED
population exceeded the theoretical maximum number
of haplotypes under the assumption of no recombina-
tion, gene conversion, or recurrent mutation (see the
“Statistical Methods” section). Overall, as might be ex-
pected (Jorde et al. 2000), the mean (28) and median
(27) number of haplotypes per gene was higher in the
AD population than in the ED population (18 and 18).
In all genes but one (IL10RA), the number of unique
haplotypes in the AD population was greater than the
number of haplotypes in the ED population.
Because all available SNPs regardless of minor allele
frequency were used to infer haplotypes, a large number
of unique haplotypes observed in each population in-
cluded haplotypes with sites observed only once (sin-
gletons) or twice (doubletons) in the population. Cor-
rectly assigning phase at rare sites using statistical
methods is challenging, particularly for singletons (Ste-
phens et al. 2001b; Lin et al. 2002). Because of the
uncertainty associated with rare sites and because it is
expected that SNPs with a minor allele frequency of at
least 5%will be more useful for genetic association stud-
ies than rare sites (Risch 2000), we reinferred haplotypes
using only sites with a minor allele frequency of 15%
(MAF 15%). By use of only common sites (MAF 15%)
from this data set, a total of 3,007, 2,263, and 1,323
haplotypes—corresponding to an average of 30, 23, and
13 haplotypes per gene—were inferred in the combined
sample and the AD and ED populations, respectively
(table 2; ﬁg. 1). The range of the number of haplotypes
per gene was similar for the AD and ED populations:
the AD population varied between 4 and 46 haplotypes,
whereas the ED population varied from 2 to 41 hap-
lotypes. As with haplotypes inferred using all sites, for
most genes, the number of distinct haplotypes was
greater in the AD population than in the ED population:
only 4 of 100 genes (HMGCR, IL1A, IL10RA, and IL2)
had a greater number of unique haplotypes in the ED
population than in the AD population.
Each gene has a distribution of haplotype frequencies
that includes rare and common haplotypes. To quantify
the number of common haplotypes in our data set, we
determined the number of haplotypes with a frequency
of 15% in each gene for both populations. The mean
number of common haplotypes per gene (frequency
15%) was 4.7, 5.0, and 4.5 in the combined sample and
the AD and ED populations, respectively. On average,
common haplotypes represented only 56% of chromo-
somes in the AD population and 75% of chromosomes
in the ED population, reﬂecting the fact that a large
proportion of chromosomes in the AD population were
represented by rare haplotypes.
Although both populations averaged approximately
the same number of common haplotypes per gene (15%
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Figure 2 The number of haplotypes per gene in the ED population is positively correlated with the number of haplotypes per gene in the
AD population. However, the correlation is not perfect ( ), and it identiﬁes genes in which the number of haplotypes per gene differs2R p 0.62
dramatically between the two populations. X-axis: number of haplotypes inferred by PHASE per gene in the AD population (MAF 15%); Y-
axis: number of haplotypes inferred by PHASE per gene in the ED population (MAF 15%).
frequency), the number and proportion of common hap-
lotypes varied greatly across genes, as well as between
the AD and ED populations. For example, atMAF 15%,
ﬁve genes did not have a single common haplotype in
the AD population (AGTR1, IL1R1, LDLR, PON1,
and SELP), whereas only one gene in the ED population
(LDLR) did not have a single common haplotype. The
lack of common haplotypes in these genes probably re-
ﬂects elevated rates of recombination, as all ﬁve genes
have weak linkage disequilibrium across the gene (Wall
and Pritchard 2003; Nickerson Group Web site). Up to
11 common haplotypes were identiﬁed in the AD pop-
ulation (F2), whereas the maximum number of common
haplotypes in the ED population was 8 (SCYA2 and
SFTPB). The proportion of chromosomes represented
by common haplotypes ranged from a low of ∼6% to
a high of 100% in both the AD and ED populations.
Because common haplotypes represent only approx-
imately half of the chromosomes in the AD population,
we sought to better describe the number of more fre-
quent haplotypes in each population by calculating the
effective number of haplotypes per gene (ne) in each pop-
ulation (see the “Statistical Methods” section). The ef-
fective number of haplotypes is the number of equally
frequent haplotypes that would produce the same ob-
served homozygosity (Hartl and Clark 1997). By use of
sites with MAF 15% to infer haplotypes, the mean num-
ber of effective haplotypes per gene was 15, 16, and 8
in the combined sample and the AD and ED populations,
respectively (ﬁg. 1).
The effective number of haplotypes is directly related
to haplotype heterozygosity (the probability that an in-
dividual carries two different haplotypes; see the “Sta-
tistical Methods” section). On average, the expected
haplotype heterozygosity was higher in the AD popu-
lation (0.92 and 0.90) than in the ED population (0.83
and 0.78), when either all SNPs or SNPs withMAF 15%
were used (table 2). At MAF 15%, haplotype hetero-
zygosity ranged from 0.67 (TNF) to 0.98 (AGTR1) in
the AD population and from 0.36 (IL5) to 0.97 (SELP)
in the ED population. For ﬁve genes (IL1A, IL10RA,
IL21R, IL10, and LTB), the expected haplotype hetero-
zygosity was higher in the ED population than in the
AD population. The higher average expected haplotype
heterozygosity in the AD population is consistent with
previous reports of haplotypes constructed from biallelic
polymorphisms in other candidate genes (Bonnen et al.
2002; Kauppi et al. 2003; Schneider et al. 2003).
Haplotype Diversity within and between Populations
As mentioned previously, the range of the number of
haplotypes per gene was similar between the AD and
ED populations. However, although the range was sim-
ilar, the number of haplotypes for speciﬁc genes varied
between populations (ﬁg. 2 and table A1 [online only]).
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Figure 3 a, Percentage (number) of shared haplotypes and pop-
ulation speciﬁc haplotypes inferred from SNPs with MAF 15% (red,
AD population–speciﬁc haplotypes; blue, ED population–speciﬁc hap-
lotypes). b, The frequency of chromosomes represented among the
shared (blackened bars) and nonshared (gray bars) haplotypes inferred
from SNPs with MAF 15%, by population. X-axis: population; Y-
axis: proportion of chromosomes represented.
These gene-to-gene differences between populations at
MAF 15% were reﬂected in the higher mean (ﬁg. 1) and
median (22 vs. 11) number of haplotypes per gene, as
well as a larger standard deviation (11 vs. 9) in the AD
population than in the ED population. Also, a linear
regression of the number of haplotypes per gene in the
ED population versus the number of haplotypes per gene
in the AD population revealed dramatic differences be-
tween populations for some genes ( ) (ﬁg. 2).2R p 0.62
For example, the genes TRPV5 and TRPV6 have many
more inferred haplotypes in the AD population (32 and
26, respectively) as compared with the ED population
(4 and 3, respectively). The dramatic differences in the
number of haplotypes for these two genes can be at-
tributed to the dramatic differences in SNP density for
these genes between the AD and ED populations (table
A1 [online only]). For other genes, the difference could
not be explained by the difference in SNP density be-
tween populations. For example, for AGT, the AD and
ED populations have approximately the same number
of SNPs per gene (56 and 58, respectively), yet the AD
population has twice as many haplotypes (25) and ef-
fective haplotypes (15.6) as the ED population (12 and
6.2, respectively), presumably because of greater histor-
ical recombination.
Recent surveys of candidate genes have suggested that
even though the AD and ED populations vary with re-
spect to the number and frequency of haplotypes, the
populations share haplotypes that account for the ma-
jority of chromosomes surveyed (Stephens et al. 2001a;
Bonnen et al. 2002; Schneider et al. 2003). To explore
this possibility in our survey, we ﬁrst examined the num-
ber of shared and nonshared haplotypes between the AD
and ED populations. We chose to base this analysis on
haplotypes inferred from the combined population be-
cause the set of SNPs with MAF 15% was different in
the AD and ED populations, making direct comparisons
between populations difﬁcult. Among the 3,007 hap-
lotypes identiﬁed using SNPs at MAF 15% in the com-
bined population (table 2), only 537 (17.9%) unique
haplotypes were shared between the AD and ED pop-
ulations (ﬁg. 3a). The majority of haplotypes observed
in the AD population (75.7%) or the ED population
(59.8%) were speciﬁc to a single population (ﬁg. 3a).
When the fraction of chromosomes represented by
shared haplotypes was considered, 42% and 70% of AD
and ED chromosomes, respectively, were represented by
shared haplotypes (ﬁg. 3b). Similarly, shared haplotypes
represented 61% of the chromosomes in the AD pop-
ulation and 85% of the chromosomes in the ED pop-
ulation when haplotypes were inferred using SNPs with
MAF 120% (data not shown). Considering similar as
well as identical haplotypes inferred using SNPs with
MAF 15% (0.02% divergent; see the “Statistical Meth-
ods” section), the fraction of chromosomes representing
shared haplotypes increased to 64% in the AD popu-
lation and 90% in the ED population (data not shown).
Haplotypes Inferred from Coding Variation
Other large resequencing surveys have targeted coding
regions for variation discovery rather than the entire
gene (Cambien et al. 1999; Cargill et al. 1999; Stephens
et al. 2001a). To compare our results with these previous
studies, we selected a subset of SNPs from our resequ-
encing survey of the entire gene to simulate a resequ-
encing strategy that targets coding regions of the gene
(see the “Material and Methods” section). In this coding
variation subset, we observed an average of 9, 10, and
7 SNPs per gene (MAF 15%), corresponding to a density
of 0.55, 0.60, and 0.41 SNPs per kb in the combined
sample and the AD and ED populations, respectively.
This is roughly one-fourth of the number of SNPs de-
tected when the entire gene sequence is considered. One
gene in the AD population (IFNG) and four genes in
the ED population (DCN, IL12A, KEL, and TNFAIP1)
did not have any sites in the coding subset. Compared
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Figure 4 The average number of haplotypes per gene (MAF
15%) using all common variation (blackened bars) and common cod-
ing variation (gray bars), by population. X-axis: population; Y-axis:
the average number of haplotypes per gene (MAF 15%). The thin bars
represent the standard deviation.
with the average number of inferred haplotypes per gene
when all available common genetic variation is used, the
average number of inferred haplotypes per gene from
coding variation at MAF 15% was considerably lower:
12, 11, and 6 versus 30, 23, and 13 in the combined
sample and the AD and ED populations, respectively
(ﬁg. 4). The observed difference between the average
number of haplotypes per gene when all common var-
iation is used, versus common coding variation, is likely
an accurate extrapolation, since the observed average
number of haplotypes when mostly coding variation is
used was similar to the data from 313 other genes pre-
sented by Stephens et al. (2001a).
Because SNP density is related to the observed number
of inferred haplotypes per gene, it is expected that the
average number of haplotypes per gene inferred from
the coding variation data set would be smaller than it
would if all common sites were used to infer haplotypes.
However, it is unknown to what extent haplotype struc-
ture is preserved when fewer sites are used to infer hap-
lotypes. For some genes, an increase in the number of
SNPs used to infer haplotypes may not necessarily result
in an increase in the number of haplotypes becausemany
sites may be correlated (in strong linkage disequilibrium)
with one another. To explore the extent of haplotype
structure preservation between discovery strategies, we
ﬁrst determined the proportion of genes whose common
haplotypes (15% frequency) were found among the hap-
lotypes inferred from common coding variation (MAF
15%). To do this, sites that uniquely identify the com-
mon haplotypes were identiﬁed either manually or by
SNPtagger (Ke and Cardon 2003) and mapped to the
haplotypes inferred from coding variation. To illustrate,
in ﬁgure 5, four common haplotypes were inferred from
all common variation in the gene IL1B in the ED pop-
ulation. In this example, three sites that uniquely identify
the common haplotypes from all common variationwere
also found in the coding variation data set for IL1B and
resolve the same common haplotypes (ﬁg. 5a). In con-
trast, for CSF2 in the AD population, only four of the
six sites that distinguish common haplotypes were found
among the coding variation data set (ﬁg. 5b). Overall,
the proﬁle identiﬁed in IL1B was in the minority, since
only 19 genes in the AD population and 27 genes in the
ED population resolved all common haplotypes when
coding variation was used.
For an alternative look at haplotype structure between
the discovery strategies, we examined the preservation
of haplotype block structure across all genes in both
populations. Blocks were deﬁned using the four-gamete
test implemented by HaploBlockFinder (Zhang and Jin
2003). The four-gamete test is a strict deﬁnition of a
haplotype block, such that there is no evidence of his-
torical recombination between a pair of sites and
(Wang et al. 2002). By use of this deﬁnition for′D p 1
haplotype blocks, a total of 1,470 and 974 blocks—
averaging 1.6 kb and 2.9 kb in size, respectively—were
identiﬁed from haplotypes inferred in the AD and ED
populations, respectively, at MAF 15%. When restricted
to common coding variation (MAF 15%), there were
considerably fewer blocks: 325 and 204 blocks, aver-
aging 3.5 kb and 4.1 kb in size, in the AD and ED
populations, respectively. Only 6 genes in the AD pop-
ulation and 21 genes in the ED population had the same
number of blocks across the gene when the two discov-
ery strategies were used to infer haplotypes and deﬁne
blocks. Similar results were observed when block bound-
aries were deﬁned using less stringent criteria (minimal
D′ range set to 0.80): only 12 genes in the AD population
and 23 genes in the ED population had the same number
of blocks across the gene when the two discovery strat-
egies were compared. Thus, only a small fraction of
genes are adequately described using coding variation,
regardless of the exact deﬁnition used to deﬁne the block
boundaries.
Discussion
We present here a comprehensive and unbiased catalog
of genetic variation and haplotype diversity in 100 can-
didate genes for inﬂammation, lipid metabolism, and
blood pressure regulation in two populations. In general,
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Figure 5 Visual depiction of the common haplotypes inferred from SNPs with MAF 15% in IL1B from the ED population (a) and CSF2
from the AD population (b). Each column represents a SNP, with the minor allele colored yellow and the common allele colored blue. Each
row represents a chromosome. Sites within the gene were clustered on the basis of allelic similarity, and haplotypes were clustered using the
unweighted pair group method with arithmetic averages. a, Four common haplotypes (15% frequency) were observed in the ED population
for IL1B from all common variation at MAF 15%. The black arrows represent tagSNPs that distinguish the four common haplotypes whose
corresponding sites were also found among the coding variation data set. b, Six common haplotypes (15% frequency) were observed in the
AD population for CSF2 from all common variation at MAF 15%. Six tagSNPs were identiﬁed that distinguish common haplotypes. The black
arrows represent the tagSNPs that distinguish common haplotypes whose corresponding sites were also found among the coding variation data
set. The red arrows represent the tagSNPs that distinguish common haplotypes whose corresponding sites were not found among the coding
variation data set.
the data demonstrated greater genetic variation in the
AD population than in the ED population, as has been
shown in studies using microsatellites (e.g., Jorde et al.
1997) and SNPs (e.g., Stephens et al. 2001a). This pat-
tern of greater genetic variation extended to the com-
parison of haplotype similarities and differences between
the populations: only a fraction of all haplotypes were
shared between the two populations examined here, and
these shared haplotypes represented fewer of the chro-
mosomes from the AD population than was expected
from previous surveys. More importantly, the number
and diversity of haplotypes varied greatly from gene to
gene, making generalities about haplotypes across can-
didate genes in the genome difﬁcult to identify. Finally,
the complete resolution of common haplotypes and
block structure was dependent on SNP density, with
complete SNP discovery leading to different inferences
of haplotype structure than incomplete SNP discovery.
These results provide a glimpse of true haplotype di-
versity across candidate genes in the human genome and
give insights into prospects for the use of haplotypes in
genetic association studies of human diseases.
Haplotype Diversity across the Human Genome
Several preliminary studies have taken steps towards
characterizing the genetic variation and haplotype di-
versity across populations and how this diversity is or-
ganized across candidate genes in the human genome.
In one such study, Stephens et al. (2001a) undertook a
large survey of coding variation discovery in 82 unre-
lated individuals in four populations for 313 genes hy-
pothesized to be involved in human disease or targets
of drug therapies. In contrast to variation-discovery
methods described by Stephens et al. (2001a), we studied
only genes that were completely resequenced for vari-
ation discovery. Thus, our data set included genetic var-
iation discovered in introns as well as repetitive se-
quences not included in other surveys, which provided
a more detailed picture of a gene’s recombinational and
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mutational history. Similar to our survey, other com-
prehensive sequence-based variation studies of single
genes or regions such as LPL (Clark et al. 1998), b-
globin (Harding et al. 1997), and ACE (Rieder et al.
1999) have revealed a level of diversity not appreciated
in studies limited to selected markers across the gene
(reviewed by Jorde et al. [2001]).
Given the comprehensive and unbiased nature of this
survey, we were able to describe haplotype diversity
among 100 genes at a level unexplored up to this point.
Not surprisingly, we found a greater number of SNPs
per gene compared with previous reports that analyzed
mostly coding-region variation (Cambien et al. 1999;
Stephens et al. 2001a; Schneider et al. 2003). With re-
gard to haplotypes, we found that the number and fre-
quency varied from gene to gene both within and be-
tween the two populations. In this data set, recom-
binational history rather than nucleotide diversity had
a greater inﬂuence on haplotype diversity, as the most
haplotype diversity was observed among genes with
weak linkage disequilibrium (Wall and Pritchard 2003;
Carlson et al. 2004). We also found that only a fraction
of the observed haplotypes were shared between the two
populations, and that these shared haplotypes repre-
sented fewer chromosomes surveyed in the AD popu-
lation than expected based on previous surveys. These
results are contrary to those published for haplotypes
inferred from coding variation, where the estimates of
chromosomes represented by shared haplotypes ex-
ceeded 75% (Stephens et al. 2001a; Schneider et al.
2003). However, our results are similar to a recent survey
of haplotype diversity across the MHC class II region
(Kauppi et al. 2003), which suggests that patterns of
haplotype diversity across the genome in global popu-
lations may be more complex than previously described.
One speciﬁc force that has been proposed to shape
haplotype diversity is the presence of hotspots of recom-
bination (Jeffreys et al. 2001; Gabriel et al. 2002). In
areas where hotspots of recombination exist, blocks of
limited haplotype diversity are ﬂanked by areas of rapid
decay in linkage disequilibrium (Jeffreys et al. 2001). It
is unclear, however, how frequently these hotspots of
recombination occur across the genome, especially given
the observation that random drift can generate similar
patterns of linkage disequilibrium (Subrahmanyan et al.
2001; Wang et al. 2002; Phillips et al. 2003; Zhang et
al. 2003). To date, only a handful of human genes have
been identiﬁed as containing hotspots either experimen-
tally (MHC class II region and beta-globin: see Jeffreys
et al. 2001; Schneider et al. 2002) or through linkage
disequilibrium studies (LPL and CD36: see Clark et al.
1998; Templeton et al. 2000; Omi et al. 2003). It is
possible that hotspots of recombination exist within a
proportion of the genes examined here, generating
greater haplotype diversity than would be observed in
a data set with genes that do not have hotspots of re-
combination. As statistical tools are being developed to
identify hotspots of recombination (Li and Stephens
2003), additional studies will be necessary to more ac-
curately assess the impact of recombination hotspots on
haplotype diversity and linkage disequilibrium across the
genome.
One caveat for the ﬁndings presented here is the fact
that we based our analyses on statistically inferred hap-
lotypes rather than on haplotypes constructed from ped-
igrees or molecular techniques. However, recent studies
that applied PHASE to molecularly determined haplo-
types demonstrated that inferred haplotypes are reason-
ably accurate when singleton SNPs are not included (Lin
et al. 2002) and that the overall estimates of haplotype
frequencies were reasonably accurate (Xu et al. 2002).
We based most of our analyses on haplotypes inferred
from biallelic polymorphisms with MAF 15%, which
excludes singletons from the data set. Also, we found
that the correlation between inferred haplotype counts
and true haplotype counts among four genes that we
tested was high (see Methods and Materials). Another
caveat is that PHASE assumes no recombination and
that we treated the “best guess” as correct, both ofwhich
will tend to lead to an under estimate of the actual num-
ber of haplotypes (M. Stephens, personal communica-
tion). A version of PHASE (v2.0) that takes recombi-
nation into account in its estimation of haplotypes was
recently released (Stephens and Donnelly 2003). The
overall results reported here are not expected to differ
signiﬁcantly from one version of PHASE to the next as
a preliminary analysis revealed very little difference in
the overall haplotype distribution inferred from PHASE
v2.0 compared with PHASE v1.01 (data not shown).
Potential Impact of Haplotype Diversity on Genetic
Association Studies
The use of haplotypes has been suggested as a tool to
capture more information across the region of interest
compared with single markers examined one at a time
(Daly et al. 2001). Also, some have suggested that hap-
lotypes rather than single SNPs may be exerting a con-
certed effect on the phenotype of interest (Drysdale et
al. 2000). Direct comparison of haplotypes across stud-
ies is difﬁcult due to differences in the haplotype infer-
ence parameters (such as minor allele frequency thresh-
olds) as well as software used to infer haplotypes. Thus,
our comparison of inferred haplotypes from the com-
plete variation data set to the coding variation data set
represents a direct comparison not possible with other
large surveys. The data presented here indicate that
many candidate genes important in the inﬂammation,
lipid metabolism, and blood pressure regulation path-
ways have a large number of haplotypes in the complete
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variation data set in these two populations. For many
genes of medical interest, such as APOB and LDLR, the
efforts to capture these haplotype patterns in a genetic
association study can be daunting with respect to the
number of sites that require genotyping. The use of
tagSNPs, SNPs useful in uniquely identifying or “tag-
ging” common haplotype patterns, has been proposed
to alleviate the costs of genotyping redundant sites while
retaining sites that contain information relevant to par-
ticular haplotypes (Johnson et al. 2001). This type of
algorithm may not be appropriate for all genes, since
common haplotypes represented only a small fraction of
chromosomes in the population surveyed for many of
the genes presented here. Another method for choosing
SNPs to be genotyped relies on the presumed biological
relevance of SNPs found in coding regions (e.g., Stephens
et al. 2001a). We demonstrate, however, that limiting a
study to coding variation haplotypes incompletely re-
solves common haplotypes and haplotype block struc-
tures that would have been observed if all common var-
iation was used to infer haplotypes. Deﬁning haplotypes
solely on the basis of coding variation could therefore
reduce the power to detect a causal variant, if the variant
is found only on a haplotype that is not uniquely re-
solved by coding SNPs but rather is grouped with other
similar haplotypes that do not carry the causal variant.
Our data demonstrate that, for most candidate genes,
knowledge of complete variation is required to design
an association study in which the sites chosen for ge-
notyping represent all common haplotypes present in the
population. Thus, methods of choosing how many and
which SNPs to genotype for an association study should
be based on complete knowledge of genetic variation of
the gene or region, since haplotype diversity is not uni-
form across candidate genes in the human genome and
can be quite complex and challenging to represent in a
study designed to identify loci contributing to common,
complex human disorders.
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